CarrACooperDAPennyR. Allergic manifestations of human immunodeficiency virus (HIV) infection. J Clin Immunol1991;11:55–64.
2.
KoopmansPPvan der VenAJVreeTBvan der MeerJW. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: Allergic or toxic?AIDS1995;9:217–22.
3.
StaalFJElaSWRoedererMAnderonMTHerzenbergLA. Glutathione deficiency and human immunodeficiency virus infection. Lancet1992;339:909–12.
4.
PirmohamedMWilliamsDTingleMDBarryMKhooSHO'Ma-HoneyCIntracellular glutathione in the peripheral blood cells of HIV-infected patients: Failure to show a deficiency. AIDS1996;10:501–7.
5.
SimonGMoogCObertG. Effects of glutathione precursors on human immunodeficiency virus replication. Chem Bio Interact1994;91:217–24.
6.
StaalFJRoedererMRajuPAAndersonMTElaSWHerzenbergLAAntioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retrovir1993;9:299–306.
7.
CarrATindallBPennyRCooperDA. In-vitro cytotoxicity as a marker of hypersensitivity to sulfamethoxazole in patients with HIV. Clin Exp Immunol1993;94:21–5.
8.
RiederMJUetrechtJShearNHCannonMMillerMSpielbergSP. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro “rechallenge” with hydoxylamine metabolites. Ann Intern Med1989;110:286–9.
9.
RiederMJShearNHKaneeATangBKSpielbergSP. Prominence of slow-acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther1991;49:13–7.
10.
ShaferRWSeitzmanPATapperML. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions. J AIDS1989;2:389–93.
11.
SchneiderMMHoepelmanAIKarelJSchattenkerkENielsenTLVan der GraafYA controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med1992;327:1836–41.
12.
CarrAPennyRCooperDA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS1993;7:65–71.
13.
FinegoldI. Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome. J Allergy Clin Immunol1996;78:905–8.
14.
PuttermanCRahavGShalitMRubinowA. “Treating through” hypersensitivity to co-trimoxazole in AIDS patients (letter). Lancet1990;336:52.
15.
AbsarNDaneshvarHBeallG. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol1994;93:1001–5.
16.
QuayBDMalinverniRLauterbergBH. Glutathione depletion in HIV-infected patients: Role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS1992;6:815–9.
